Stay updated on Emricasan in NASH Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.

Latest updates to the Emricasan in NASH Fibrosis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. This update does not alter study details or page functionality.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedFooter update: Revision v3.4.2 added and Revision v3.4.1 removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page shows a minor system revision update (Revision: v3.4.1) with no changes to study content, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange DetectedUI/text changes include showing/hiding glossary, capitalization tweaks to QC-related labels, and a new Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4 with no obvious changes to core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check89 days agoChange DetectedThe study's Locations section was updated to reflect new and reorganized site listings across the United States and Germany (including North Rhine-Westphalia). This change is accompanied by a page revision note: v3.3.3.SummaryDifference2%

Stay in the know with updates to Emricasan in NASH Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.